ES2142817T3 - Compuestos triciclicos como antagonistas de la angiotensina ii. - Google Patents

Compuestos triciclicos como antagonistas de la angiotensina ii.

Info

Publication number
ES2142817T3
ES2142817T3 ES92311777T ES92311777T ES2142817T3 ES 2142817 T3 ES2142817 T3 ES 2142817T3 ES 92311777 T ES92311777 T ES 92311777T ES 92311777 T ES92311777 T ES 92311777T ES 2142817 T3 ES2142817 T3 ES 2142817T3
Authority
ES
Spain
Prior art keywords
chem
alkyl
carboxyl
substituted phenyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92311777T
Other languages
English (en)
Inventor
Etsuo Ohshima
Fumihiko Kanai
Hideyuki Sato
Hiroyuki Obase
Toshiaki Kumazawa
Shiho Takahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of ES2142817T3 publication Critical patent/ES2142817T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PRESENTAN NUEVOS COMPUESTOS TRICICLICOS Y SALES DE LOS MISMOS QUE SON UTILES COMO ANTAGONISTAS RECEPTORES DE LA AII. ESTOS SON LOS COMPUESTOS DE LA FORMULA I Y SUS SALES: R1 REPRESENTA HIDROGENO, HALOGENO O ALQUIL C1-C6; A REPRESENTA CIANO, CARBOXIL, TETRAZOLIL, FENIL SUSTITUIDO CON CIANO, FENIL SUSTITUIDO CON CARBOXIL O FENIL SUSTITUIDO CON TETRAZOLIL; C REPRESENTA -(CH2)M-, EN DONDE M ES 0, 1 O 2; W REPRESENTA UN GRUPO DE LA FORMULA EN DONDE (ALFA) ES: EN DONDE R2, R3 Y R4 SON CADA UNA HIDROGENO, HALOGENO, ALQUIL C1C6, CICLOALQUIL C2-C6, ALQUIL C1-C6 HALOGENADO, HIDROXIDO, ALCOXIDO C1-C6, AMINO, ALQUILAMINO C1-C6, CARBOXIL O ALCOXICARBONIL C1-C6; Y Q1-Q2-Q3-Q4 REPRESENTAN N=CH-CH=CH, CH=CH-CH=CH O CH2-CH2-CH2-CH2; (BETA) ES: EN DONDE R2, R3 Y R4 SON CADA UNA COMO SE DEFINIERON ANTERIORMENTE GAMMA ES EN DONDE R5 Y R6 REPRESENTAN CADA UNA HIDROGENO, ALQUIL C1-C6 O CICLOALQUIL C3-C5, Y R7 REPRESENTA CARBOXIL, ALCOXICARBONIL C1C6, CARBAMOIL O HIDROXIMETIL; Y (DELTA) ES: EN DONDE R8 Y R9 REPRESENTAN CADA UNA HIDROGENO O ALQUIL C1-C6, Y Q REPRESENTA N O CH; X1-X2-X3 REPRESENTAN UN GRUPO CH=CH, CH-CH2, CH-CH(COOH)
ES92311777T 1991-12-27 1992-12-24 Compuestos triciclicos como antagonistas de la angiotensina ii. Expired - Lifetime ES2142817T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34729491 1991-12-27

Publications (1)

Publication Number Publication Date
ES2142817T3 true ES2142817T3 (es) 2000-05-01

Family

ID=18389240

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92311777T Expired - Lifetime ES2142817T3 (es) 1991-12-27 1992-12-24 Compuestos triciclicos como antagonistas de la angiotensina ii.

Country Status (4)

Country Link
EP (1) EP0549352B1 (es)
AT (1) ATE190058T1 (es)
DE (1) DE69230721T2 (es)
ES (1) ES2142817T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716196B1 (fr) * 1994-02-16 1996-04-05 Synthelabo Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.
JP2002541144A (ja) * 1999-01-26 2002-12-03 ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド 医薬的に活性のある化合物及びその使用方法
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
US20060252679A1 (en) * 2002-08-22 2006-11-09 Mayumi Saki Preventive and/or trerapeutic drgs for itch
WO2004017994A1 (ja) * 2002-08-22 2004-03-04 Kyowa Hakko Kogyo Co., Ltd. 喘息の予防および／または治療剤
EP1988091B1 (en) * 2007-02-07 2015-06-10 Kyowa Hakko Kirin Co., Ltd. Tricyclic compounds
JP5559689B2 (ja) * 2008-08-06 2014-07-23 協和発酵キリン株式会社 ３環系化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
DE59107440D1 (de) * 1990-02-19 1996-04-04 Ciba Geigy Ag Acylverbindungen

Also Published As

Publication number Publication date
DE69230721D1 (de) 2000-04-06
ATE190058T1 (de) 2000-03-15
EP0549352A2 (en) 1993-06-30
DE69230721T2 (de) 2000-08-31
EP0549352A3 (en) 1993-07-28
EP0549352B1 (en) 2000-03-01

Similar Documents

Publication Publication Date Title
AU680704B2 (en) Cyclic amide derivatives
EP0152820A3 (en) Carbamate compounds, compositions and method of making the same
FI830776L (fi) Nya foereningar, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel
ATE163647T1 (de) 4-aminopyrimidin derivate
EP0632031A4 (es)
ES2142817T3 (es) Compuestos triciclicos como antagonistas de la angiotensina ii.
DK0459505T3 (da) Imidazonaphthyridinderivater
EP1306369A4 (en) NEW SULFUR COMPOUNDS AND INTERMOLECULAR COMPOUNDS CONTAINING THEM AS A COMPONENT
AU3667589A (en) Thiophenol derivatives as collagenese inhibitors
DK221490D0 (da) Beta-carbonyl-carboxyamider af 1,3-thiazolidiner
SE8303913D0 (sv) Heterocykliska foreningar
SE8505369D0 (sv) New thienopyridine derivatives, a process of preparation thereof and therapeutic compositions containing the same
IE821782L (en) Sulphimines
ES2096628T3 (es) Derivados heterociclicos.
DE69004596D1 (de) Benzodiazepin-Analoge.
DK0481742T3 (da) Piperazinderivater
PL321309A1 (en) Novel bis-imide compounds, method of obtaining them and pharmaceutic compositions containing such compounds
DE69427100D1 (de) Herstellung von Beta-lactamverbindungen und Zwischenprodukte
DE69420362D1 (de) Makrozyklische Verbindungen und ihre Verwendung als Pharmazeutika
NO872006D0 (no) Fremgangsmaate for fremstilling av cefalosporinderivater.
ATE329917T1 (de) 1h-pyrrolo 1,2-bö 1,2,4ötriazolederivate, zwischenprodukte und verfahren zur herstellung von 1h-1,2,4,-triazol-5-yl essigsäureesterderivate
ATE109764T1 (de) Beta-lactamverbindungen und deren herstellung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 549352

Country of ref document: ES